Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blanchet

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Behavioural Brain Research|December 2, 2008
Motor sequence learning in primate: role of the D2 receptor in movement chunking during consolidationPierre-Luc Tremblay, Marc-Andre Bedard, Maxime Levesque, et al.
Annals of Neurology|April 13, 2000
Molecular basis of levodopa-induced dyskinesiasF Calon, R Grondin, M Morissette, et al.
Experimental Neurology|April 29, 2000
125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatmentsF Calon, M Morissette, M Goulet, et al.
Neuroscience|July 1, 1997
Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysisM Goulet, M Morissette, F Calon, et al.
Journal of Psychiatric Research|March 6, 2012
Contribution of orodental status to the intensity of orofacial tardive dyskinesia: an interdisciplinary and video-based assessmentPhilippe Girard, Claude Monette, Louise Normandeau, et al.
Journal of Clinical Medicine|May 25, 2024
Impacts of ADHD Symptomatology on the Response to Cognitive-Behavioural Therapy with Gilles de la Tourette Syndrome PatientsEmmanuelle Mazur-Lainé, Houda Soubata, Julie B Leclerc, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeysP J Blanchet, S Konitsiotis, E R Whittemore, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2003
Complications of a trophic xenotransplant approach in parkinsonian monkeysPierre J Blanchet, Spiros Konitsiotis, Hideki Mochizuki, et al.
Journal of Parkinson'S Disease|May 31, 2018
Cardinal Motor Features of Parkinson's Disease Coexist with Peak-Dose Choreic-Type Drug-Induced DyskinesiaEtienne Goubault, Hung P Nguyen, Sarah Bogard, et al.
Brain Research. Molecular Brain Research|December 5, 1997
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapyM Morissette, M Goulet, J J Soghomonian, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Behavioural Brain Research|December 2, 2008
Motor sequence learning in primate: role of the D2 receptor in movement chunking during consolidationPierre-Luc Tremblay, Marc-Andre Bedard, Maxime Levesque, et al.
Annals of Neurology|April 13, 2000
Molecular basis of levodopa-induced dyskinesiasF Calon, R Grondin, M Morissette, et al.
Experimental Neurology|April 29, 2000
125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatmentsF Calon, M Morissette, M Goulet, et al.
Neuroscience|July 1, 1997
Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysisM Goulet, M Morissette, F Calon, et al.
Journal of Psychiatric Research|March 6, 2012
Contribution of orodental status to the intensity of orofacial tardive dyskinesia: an interdisciplinary and video-based assessmentPhilippe Girard, Claude Monette, Louise Normandeau, et al.
Journal of Clinical Medicine|May 25, 2024
Impacts of ADHD Symptomatology on the Response to Cognitive-Behavioural Therapy with Gilles de la Tourette Syndrome PatientsEmmanuelle Mazur-Lainé, Houda Soubata, Julie B Leclerc, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999
Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeysP J Blanchet, S Konitsiotis, E R Whittemore, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2003
Complications of a trophic xenotransplant approach in parkinsonian monkeysPierre J Blanchet, Spiros Konitsiotis, Hideki Mochizuki, et al.
Journal of Parkinson'S Disease|May 31, 2018
Cardinal Motor Features of Parkinson's Disease Coexist with Peak-Dose Choreic-Type Drug-Induced DyskinesiaEtienne Goubault, Hung P Nguyen, Sarah Bogard, et al.
Brain Research. Molecular Brain Research|December 5, 1997
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapyM Morissette, M Goulet, J J Soghomonian, et al.
Pageof 11